Live feed
Filing
SC 13G/A
SC 13G/A0001623632-15-001801·FEDERATED HERMES, INC.
Schedule 13G ownership disclosure
Protalix BioTherapeutics, Inc.
Security class unavailable · CUSIP: 74365A101
Event date: 2015-10-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 925,604
- Percent of class
- 0.9800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001623632-15-001801
- Form type
- SC 13G/A
- Filer
- FEDERATED HERMES, INC.
- CIK
- CIK 1056288
- Filed
- Nov 10, 2015
- Reporting period
- Oct 31, 2015
- Description
- Schedule 13G beneficial ownership